Pain
Conditions
Interventions
A parallel, double-blind, randomized clinical trial will be conducted with 120 patients undergoing chemotherapy, including dental oral clinical assessment and fluorescence visualization method. Patien
Group II – application of Germinator™) and a control group (Group III – application of low level laser therapy at 803 nm wavelength), comparing clinical outcomes and length of hospital stay among the
E02.774
Sponsors
Hospital Nossa Senhora da Conceição
Universidade de Passo Fundo
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Diagnosed with head and neck cancer (oral cavity, oropharynx and nasopharynx); both genders; chemotherapy for treatment of cancer; no painful symptoms; no diagnosis of oral mucositis
Exclusion criteria
Exclusion criteria: Patients who had already undergone chemotherapy treatment; any grade higher tan 0 in the Visual Analogic Scale (VAS) of painful symptoms; grade I, II, III or IV oral mucositis; using medications to control oral mucositis; patients who did not agree to participate
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Primary
| Measure | Time frame |
|---|---|
| A statistically significant difference is expected to be found between the tested protocols in the prevention of painful symptoms and oral mucositis, after the experimental evaluation period (p>0.05). | — |
Countries
Brazil, United States
Contacts
Public ContactJoão De Carli
Universidade de Passo Fundo
Outcome results
None listed